URI: 
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TYSABRI (natalizumab)
       *****************************************************
       #Post#: 2823--------------------------------------------------
       (Abst.) Effect of switching from Tysabri to moderate- vs. high-e
       fficacy DMT in clinical practice
       By: agate Date: February 24, 2020, 11:52 pm
       ---------------------------------------------------------
       From Neurology Clinical Practice (February 12, 2020), "Effect of
       switching from natalizumab to moderate- vs. high-efficacy DMT
       in clinical practice"
  HTML https://cp.neurology.org/content/early/2020/02/12/CPJ.0000000000000809
       #Post#: 2919--------------------------------------------------
       Natalizumab switch to moderate-efficacy DMT increases disability
        risk
       By: agate Date: May 30, 2020, 1:45 am
       ---------------------------------------------------------
       More on this from Medscape (May 27, 2020)--"Natalizumab switch
       to moderate-efficacy DMT  increases disability risk":
  HTML https://www.medscape.com/viewarticle/931195
       *****************************************************